Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2003
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049662 Oligonucleotides for use in the treatment of wounds, cardiovascular, cell proliferative and developmental disorders
03/13/2003US20030049289 Cosmetic or dermatological preparations of the oil-in-water type
03/13/2003US20030049287 Catechol oximes and their use in cosmetic and dermatological preparations
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049271 Diagnosis, therapy of bacteria infections
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049231 Therapy for skin disorders; human or veterinary medicine
03/13/2003US20030049213 Melanin production inhibitors and skincare products containing such inhibitors
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2459413A1 Methods for sterilizing preparations containing albumin
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003CA2457861A1 Piperidine derivatives useful as ccr5 antagonists
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291022A1 Methods of using lanreotide, a somatostatin analogue
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291018A1 Pharmaceutical composition
03/12/2003EP1291011A1 Hand treatment lotion
03/12/2003EP1291008A2 Screening composition containing at least one dibenzoylmethane derivative and 1,1,1-tri-(2-methyl-4-hydroxy-5-tert-butylphenyl)-butane
03/12/2003EP1290939A1 Caspase 1 gene transfer animal
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290188A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof
03/12/2003EP1290152A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/12/2003EP1290012A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289945A1 Aniline disulfide derivatives for treating allergic diseases
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289558A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289537A2 Method of treating chronic ulcers
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289533A1 Whitening compositions containing ascomycete derived enzyme
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289516A1 Composition for pain mediation and apparatus and method of use thereof
03/12/2003EP1289492A1 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals
03/12/2003EP1289491A1 Cosmetic and/or dermatological composition based on cocoa extracts
03/12/2003EP1289475A2 Water-thin emulsions with low emulsifier levels
03/12/2003EP1289383A1 Primary composition containing a lipophilic bioactive compound
03/12/2003EP1135148B1 Enteral pharmaceutical preparation
03/12/2003EP1075477B1 Novel Benzonaphthyridine-N-oxides
03/12/2003EP0991412B1 Aminoacyl sulfamides for the treatment of hyperproliferative disorders
03/12/2003EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0895478B1 Component b as cicatrizant
03/12/2003EP0884950B1 A method of killing or inhibiting microbial cells
03/12/2003EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402730A Thiazolo (4,5-D) pyrimidine compounds
03/12/2003CN1402729A Polycycloalkylpurines as adenosine receptor antagonists
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1401637A Process for preparing norfloxacin silver as antiinfection medicine for burns
03/12/2003CN1401365A Chinese health medicine
03/12/2003CN1401359A Medicine for treating hand and foot tinea and ringworm of nails
03/12/2003CN1401350A Medicine for treating burns and scald, and producing method thereof
03/12/2003CN1401345A Medicine for treating athlete's foot for external use and producing method thereof
03/12/2003CN1401336A Medicine of treating dermatosis for external use
03/12/2003CN1401333A Process for producing biopreparation with special acne, comedo and folliculitis treatment effect
03/12/2003CN1401323A Compound ointment for treating fungous dermatosis
03/12/2003CN1401317A Use of bismuth subgallate in suppressing formation of nitrogen oxide synthetase
03/12/2003CN1401315A Cold spring volcanic mud and pure bioactive factor composition and producing method thereof
03/12/2003CN1102849C Use of octopirox as depigmenting agent
03/12/2003CA2399338A1 Swab deliverable actives
03/11/2003US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
03/11/2003US6531500 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering by administering an oil-in-water emulsion comprising: (a) allantoin; and (b) an emulsifier system including beeswax and an anionic emulsifier
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003US6531164 Enteral pharmaceutical preparation
03/11/2003US6531140 Anti-irritant compositions containing a cyclic nucleotide
03/11/2003US6531134 Mammalian milk growth factor
03/11/2003CA2264254C Phosphinic acid amides as matrix metalloprotease inhibitors
03/11/2003CA2085605C Stimulation of hair growth with potassium channel openers and 5alpha-reductase inhibitors
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018836A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018748A2 Anti-cancer and wound healing compounds
1 ... 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 ... 1065